Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Sales | 627 | 0 | 0 | 0 |
| Gross Profit | 627 | N/A | N/A | N/A |
| Operating Expenses | 21,140 | 21,332 | 0 | 0 |
| Operating Income | -20,513 | -21,332 | N/A | N/A |
| Other Income | -3,606 | 1,504 | 0 | 0 |
| Pre-tax Income | -24,119 | -19,828 | 0 | 0 |
| Net Income Continuous | -24,119 | -19,828 | N/A | N/A |
| Net Income | $-24,119 | $-19,828 | $N/A | $N/A |
| EPS Basic Total Ops | -1,519.27 | -453.02 | N/A | N/A |
| EPS Basic Continuous Ops | -354.69 | -341.86 | N/A | N/A |
| EPS Diluted Total Ops | -1,519.27 | -453.02 | N/A | N/A |
| EPS Diluted Continuous Ops | -354.69 | -341.86 | N/A | N/A |
| EBITDA(a) | $-19,427 | $-21,231 | $N/A | $N/A |